Abstract
The nucleoside analogue, 2',3'-dideoxycytidine (ddC), is a potent inhibitor of HIV replication, and AIDS patients receiving ddC experience clinical improvement without significant hematologic toxicity. Repeated ddC administration (1,000 mg/kg per day) for 13 wk produces an increased incidence of thymic lymphoma in B6C3F1 mice. Previous studies reveal a common link between chemically induced and genetically associated models of mouse thymic lymphoma that involves a defect in a subpopulation of primitive hematopoietic progenitor cells. This defect is characterized by suppression of a subpopulation of IL-3-responsive cells and ablation of stem cell factor synergy with GM-CSF. The present study was undertaken to ascertain whether ddC produces the same pattern of bone marrow toxicity in mice, and whether this effect is observed in rat and human bone marrow. ddC exposure in vivo and in vitro produced a select suppression of murine CFU identical to that previously described for other models of mouse thymic lymphoma. In contrast, this selective CFU suppression was not observed in rat and human bone marrow or in CD34+ cells. These studies suggest that the mouse may not be a good predictive model for ddC hematotoxicity in humans and that...Continue Reading
References
May 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·A G LearyM Ogawa
Oct 5, 1990·Cell·D E WilliamsH S Boswell
Oct 5, 1990·Cell·O N Witte
May 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·H J SutherlandC J Eaves
Jun 1, 1990·Environmental Health Perspectives·P E Owen, J R Glaister
Apr 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·H MitsuyaS Broder
Sep 1, 1988·Nature·B ChabotA Bernstein
Mar 1, 1988·Biochemical Pharmacology·J BalzariniD G Johns
Jan 16, 1988·Lancet·R YarchoanM C McNeely
Sep 30, 1986·Toxicology and Applied Pharmacology·R D IronsL J Leiderman
Jul 23, 1987·The New England Journal of Medicine·D D RichmanM S Hirsch
May 1, 1987·American Industrial Hygiene Association Journal·P E OwenD H Pullinger
Feb 1, 1985·Current Problems in Cancer·F A Dorr, C A Coltman
Mar 30, 1986·Toxicology and Applied Pharmacology·R D IronsL J Leiderman
Nov 1, 1984·Journal of Cellular Physiology·M A WaqarJ A Huberman
Apr 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·D B ColagiovanniR D Irons
Citations
Jul 29, 2000·Biochemical and Biophysical Research Communications·D W PyattR D Irons
Oct 28, 1996·Toxicology·R D IronsW S Stillman
Jun 9, 2001·Chemico-biological Interactions·R D IronsJ Hua Zheng
Sep 21, 2000·Toxicology·R D IronsJ A Ruth
Mar 29, 2003·Journal of Virology·David WarrenNaomi Rosenberg
Jan 1, 2004·Molecular and Cellular Biology·Gurpreet S KapoorDonald M O'Rourke
Apr 1, 2003·Molecular and Cellular Biology·Nina JonesDaniel J Dumont
Mar 16, 2006·Molecular and Cellular Biology·Mingming ZhaoLinda Van Aelst
Apr 16, 2005·Molecular and Cellular Biology·Paul Van SlykeDaniel J Dumont
Jan 1, 1997·Critical Reviews in Toxicology·M W HimmelsteinJ A Bond
Feb 29, 2000·Molecular Pharmacology·D W PyattR D Irons